Wearable Data Revolution

There is no doubt the age of wearable monitors is upon us. Sales of physical activity monitors have increased dramatically from 15 million in...

Tempus Attracts $200M in Series F Financing, Bringing Total Raised to $510M

Tempus, a precision medicine technology company focused on collecting and analyzing molecular and clinical data, has raised $200 million in Series F financing, bringing...
Biotechnology, conceptual illustration

Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer

Concerto HealthAI announced today the company entered a precision oncology collaboration with Pfizer using Concerto HealthAI’s eurekaHealth platform, artificial intelligence (AI) models and data...

AI Finds Mutations in “Junk” DNA that Cause Autism

A team of Princeton University-led researchers has used an artificial intelligence algorithm to identify mutations in “junk” DNA that can cause autism. The findings,...

Clinical Trials Data Partnership Joins Verily with Pharma Giants

Verily Life Sciences, the healthcare subsidiary of Google parent Alphabet, said today it will partner with four pharma giants—Novartis, Otsuka Pharmaceutical, Pfizer, and Sanofi—to...
Precision for Medicine has acquired machine learning-based technology developer SimplicityBio for an undisclosed price

Precision for Medicine Acquires SimplicityBio, Adding AI to QuartzBio Platform

Buyer aims to help pharmaceutical, diagnostic developers maximize the value and utility of biomarker data generated through clinical trials
Source: Philips Healthcare

Philips to Deploy Dana-Farber Clinical Pathways for Cancer Care

Philips will make the tool for cancer care available via its IntelliSpace Oncology Platform to map patients to the most appropriate care
Gemome Sequence Map

Big Data and Clinical Genomics

Progress Is Being Made Toward Using Big Data for Genomics-Guided Precision Medicine Precision medicine springs from a paradox. On the one hand, researchers in the...

Rady Researchers Use AI ‘Pipeline’ for Rapid Diagnosis of Rare Genetic Diseases

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) have built an automated pipeline designed to deliver a potential diagnosis in record time for hospitalized...
GenomeDx Biosciences will use its Decipher Prostate Cancer Classifier tests

Janssen Pharmaceuticals to Use GenomeDx Prostate Cancer Tests, Database

Companies plan to examine the association of signatures available on GenomeDx’s Decipher GRID database with clinical outcomes.
Scroll Up